Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

QBREXZA

GLYCOPYRRONIUM TOSYLATE

Standard Dose
EQ 2.4% BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview QBREXZA is listed in Drugs@FDA under application 210361 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient GLYCOPYRRONIUM TOSYLATE Form and strength CLOTH;TOPICAL - EQ 2.4% BASE Sponsor JOURNEY Submission history Latest submission status date: 2022-10-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview QBREXZA is listed in Drugs@FDA under application 210361 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GLYCOPYRRONIUM TOSYLATE Form and strength CLOTH;TOPICAL - EQ 2.4% BASE Sponsor JOURNEY Submission history Latest submission status date: 2022-10-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.